| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1034015911 |
| P356 | DOI | 10.1007/S00424-012-1146-3 |
| P8608 | Fatcat ID | release_hwbiakrc6bgmfg67nloktr4pbe |
| P932 | PMC publication ID | 3548020 |
| P698 | PubMed publication ID | 22949090 |
| P2093 | author name string | Robert M Carey | |
| Shetal H Padia | |||
| P2860 | cites work | Renal Dopamine System | Q22241910 |
| Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients | Q24324656 | ||
| Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries | Q24338401 | ||
| Disruption of the Ang II type 1 receptor promotes longevity in mice | Q24647615 | ||
| International union of pharmacology. XXIII. The angiotensin II receptors | Q28138041 | ||
| Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide | Q28205318 | ||
| Sex difference in vascular injury and the vasoprotective effect of valsartan are related to differential AT2 receptor expression | Q28267569 | ||
| Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors | Q28569701 | ||
| Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney | Q28571109 | ||
| Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat | Q28580248 | ||
| Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model | Q30304002 | ||
| Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats | Q30305670 | ||
| Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats | Q30308406 | ||
| Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation | Q30310896 | ||
| Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice | Q30311190 | ||
| Mechanisms of dopamine D(1) and angiotensin type 2 receptor interaction in natriuresis | Q30422595 | ||
| Angiotensin II Type-2 receptors modulate inflammation through signal transducer and activator of transcription proteins 3 phosphorylation and TNFα production. | Q30426697 | ||
| Identification and characterization of a functional mitochondrial angiotensin system | Q30427934 | ||
| Angiotensin AT₂ receptor stimulation inhibits early renal inflammation in renovascular hypertension | Q30432916 | ||
| ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development | Q30434317 | ||
| Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation | Q30435059 | ||
| Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age. | Q30436078 | ||
| Intrarenal dopamine D1-like receptor stimulation induces natriuresis via an angiotensin type-2 receptor mechanism | Q30442186 | ||
| Intrarenal aminopeptidase N inhibition augments natriuretic responses to angiotensin III in angiotensin type 1 receptor-blocked rats | Q30442448 | ||
| Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuresis in rats | Q30445290 | ||
| Intact microtubules are required for natriuretic responses to nitric oxide and increased renal perfusion pressure | Q30445338 | ||
| The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats | Q30448817 | ||
| The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats | Q30448844 | ||
| Receptor recruitment: a mechanism for interactions between G protein-coupled receptors | Q30454331 | ||
| Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane | Q30454416 | ||
| Renin-angiotensin system modulates renal bradykinin production | Q30469571 | ||
| Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide | Q30470112 | ||
| Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney | Q30471269 | ||
| Immunolocalization of subtype 2 angiotensin II (AT2) receptor protein in rat heart | Q30472368 | ||
| Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. | Q33685969 | ||
| Angiotensin II stimulates thick ascending limb NO production via AT(2) receptors and Akt1-dependent nitric-oxide synthase 3 (NOS3) activation | Q33832746 | ||
| Angiotensin-(1-7): an update. | Q34019825 | ||
| Inhibition of NAD(P)H oxidase potentiates AT2 receptor agonist-induced natriuresis in Sprague-Dawley rats | Q34211604 | ||
| The angiotensin IV/AT4 receptor. | Q34368921 | ||
| Glucocorticoid-induced fetal programming alters the functional complement of angiotensin receptor subtypes within the kidney | Q34586584 | ||
| Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism | Q34990858 | ||
| Angiotensin AT2 receptors: cardiovascular hope or hype? | Q35045801 | ||
| Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor‐mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide | Q35045808 | ||
| Role of angiotensin III in hypertension | Q36062241 | ||
| Angiotensin II type 2 receptor-mediated inhibition of NaCl absorption is blunted in thick ascending limbs from Dahl salt-sensitive rats | Q36190829 | ||
| Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs | Q36210919 | ||
| Angiotensin II AT(2) receptor decreases AT(1) receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats | Q36994675 | ||
| Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. | Q37098279 | ||
| Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production | Q37216933 | ||
| AT2 receptors: functional relevance in cardiovascular disease. | Q37274124 | ||
| Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond | Q37633670 | ||
| AT2 receptor agonists: hypertension and beyond | Q37976927 | ||
| Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation | Q40851849 | ||
| In vivo PTH provokes apical NHE3 and NaPi2 redistribution and Na-K-ATPase inhibition | Q41665446 | ||
| Protective role of angiotensin II subtype 2 receptor in blood pressure increase in obese Zucker rats | Q41820888 | ||
| AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions | Q42014112 | ||
| Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. | Q42740981 | ||
| Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. | Q43071456 | ||
| Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion | Q43637801 | ||
| AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade | Q44167938 | ||
| Recruitment of renal dopamine 1 receptors requires an intact microtubulin network | Q44360499 | ||
| Sex differences in the pressor and tubuloglomerular feedback response to angiotensin II. | Q44595252 | ||
| Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model. | Q44635426 | ||
| Up-Regulation of Angiotensin II Type 2 Receptor in Rat Thoracic Aorta by Pressure-Overload | Q44650642 | ||
| Stimulation of cyclic GMP production via AT2 and B2 receptors in the pressure-overloaded aorta after banding | Q44881068 | ||
| Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors | Q44886524 | ||
| Angiotensin II-dependent induction of AT(2) receptor expression after renal ablation | Q45059001 | ||
| Renal angiotensin II type-2 receptors are upregulated and mediate the candesartan-induced natriuresis/diuresis in obese Zucker rats | Q45185681 | ||
| Angiotensin II dilates bovine adrenal cortical arterioles: role of endothelial nitric oxide | Q46487926 | ||
| Renal angiotensin II AT2 receptors promote natriuresis in streptozotocin-induced diabetic rats | Q46735589 | ||
| Angiotensin II AT2 receptors inhibit proximal tubular Na+-K+-ATPase activity via a NO/cGMP-dependent pathway | Q46870152 | ||
| Sex-specific influence of angiotensin type 2 receptor stimulation on renal function: a novel therapeutic target for hypertension. | Q51376910 | ||
| Gender differences in pressure-natriuresis and renal autoregulation: role of the Angiotensin type 2 receptor. | Q51525795 | ||
| Angiotensin III stimulates aldosterone secretion from adrenal gland partially via angiotensin II type 2 receptor but not angiotensin II type 1 receptor. | Q54388735 | ||
| Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive rats | Q73699573 | ||
| Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase | Q79326913 | ||
| Effects of angiotensin II and its metabolites in the rat coronary vascular bed: is angiotensin III the preferred ligand of the angiotensin AT2 receptor? | Q81356302 | ||
| Angiotensin II type 2 receptor agonist directly inhibits proximal tubule sodium pump activity in obese but not in lean Zucker rats | Q83161979 | ||
| P433 | issue | 1 | |
| P921 | main subject | circulatory system | Q11068 |
| P304 | page(s) | 99-110 | |
| P577 | publication date | 2012-09-05 | |
| P1433 | published in | Pfluegers Archiv | Q1091689 |
| P1476 | title | AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function | |
| P478 | volume | 465 |
| Q61443913 | A Series of Analogues to the ATR Prototype Antagonist C38 Allow Fine Tuning of the Previously Reported Antagonist Binding Mode |
| Q39319793 | AT1 receptor signaling pathways in the cardiovascular system |
| Q30276542 | AT2 Receptor Activation Prevents Sodium Retention and Reduces Blood Pressure in Angiotensin II-Dependent Hypertension |
| Q30275852 | AT2 Receptors: Potential Therapeutic Targets for Hypertension |
| Q36052778 | AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction |
| Q30375544 | AT₂ receptor activation induces natriuresis and lowers blood pressure. |
| Q48136457 | Acute simvastatin treatment restores cerebral functional capillary density and attenuates angiotensin II-induced microcirculatory changes in a model of primary hypertension |
| Q38930138 | Angiotensin 2 type 1 receptor blockade different affects postishemic kidney injury in normotensive and hypertensive rats. |
| Q89006965 | Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology |
| Q35920857 | Angiotensin II Type 2 Receptor Decreases Transforming Growth Factor-β Type II Receptor Expression and Function in Human Renal Proximal Tubule Cells |
| Q47242663 | Angiotensin II type 2 receptor inhibits expression and function of insulin receptor in rat renal proximal tubule cells. |
| Q38110281 | Angiotensin-II-derived reactive oxygen species on baroreflex sensitivity during hypertension: new perspectives. |
| Q50193317 | Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models |
| Q30253015 | Blood Pressure and the Renal Actions of AT2 Receptors |
| Q50089166 | Blood pressure regulation by the angiotensin type 1 receptor in the proximal tubule |
| Q58728382 | Cell-Specific Protective Signaling Induced by the Novel AT2R-Agonist NP-6A4 on Human Endothelial and Smooth Muscle Cells |
| Q58699775 | Chronic administration of the angiotensin type 2 receptor agonist C21 improves insulin sensitivity in C57BL/6 mice |
| Q34809342 | Commercially available angiotensin II At₂ receptor antibodies are nonspecific. |
| Q36975699 | Comparison of Efficacy of Long-term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease |
| Q37327417 | Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging. |
| Q30417367 | Diagnostic tools for hypertension and salt sensitivity testing. |
| Q28533596 | Differential mechanisms of activation of the Ang peptide receptors AT1, AT2, and MAS: using in silico techniques to differentiate the three receptors |
| Q90759679 | Effect of early postnatal nutrition on chronic kidney disease and arterial hypertension in adulthood: a narrative review |
| Q95832482 | GABA is a mediator of brain AT1 and AT2 receptor-mediated blood pressure responses |
| Q99239317 | High affinity rigidified AT2 receptor ligands with indane scaffolds |
| Q89924048 | High-dose nitrate therapy recovers the expression of subtypes α1 and β-adrenoceptors and Ang II receptors of the renal cortex in rats with myocardial infarction-induced heart failures |
| Q33809582 | Hypotensive Response to Angiotensin II Type 2 Receptor Stimulation in the Rostral Ventrolateral Medulla Requires Functional GABA-A Receptors |
| Q35601958 | Hypotensive and sympathoinhibitory responses to selective central AT2 receptor stimulation in spontaneously hypertensive rats |
| Q38561435 | Immune-mediated pathology in Duchenne muscular dystrophy |
| Q38737743 | In Utero Origins of Hypertension: Mechanisms and Targets for Therapy |
| Q89835347 | Inhibition of Angiotensin-Converting Enzyme Ameliorates Renal Fibrosis by Mitigating DPP-4 Level and Restoring Antifibrotic MicroRNAs |
| Q35564416 | Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands |
| Q36241932 | International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. |
| Q37696631 | Intrarenal renin-angiotensin system in regulation of glomerular function |
| Q48315547 | Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial. |
| Q31160630 | N-Aryl Isoleucine Derivatives as Angiotensin II AT2 Receptor Ligands |
| Q41298028 | Overexpression of ANO1/TMEM16A, an arterial Ca2+-activated Cl- channel, contributes to spontaneous hypertension |
| Q36785528 | ROS and endothelial nitric oxide synthase (eNOS)-dependent trafficking of angiotensin II type 2 receptor begets neuronal NOS in cardiac myocytes. |
| Q89958002 | Recent Research Advances in Renin-Angiotensin-Aldosterone System Receptors |
| Q38834345 | Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration. |
| Q43108831 | Response to letter regarding article, "AT2 receptor activation induces natriuresis and lowers blood pressure". |
| Q97074100 | Role of the Backbenchers of the Renin-Angiotensin System ACE2 and AT2 Receptors in COVID-19: Lessons From SARS |
| Q38287148 | Salt feedback on the renin-angiotensin-aldosterone system |
| Q51139130 | Sex-specific effects of low protein diet on in utero programming of renal G-protein coupled receptors. |
| Q36400573 | Small-molecule AT2 receptor agonists |
| Q35220595 | Structural libraries of protein models for multiple species to understand evolution of the renin-angiotensin system |
| Q38129928 | Targeting the 'Janus face' of the B2-bradykinin receptor |
| Q42261440 | The intracellular angiotensin system buffers deleterious effects of the extracellular paracrine system |
| Q38253635 | The role of local renin-angiotensin system in arterial chemoreceptors in sleep-breathing disorders |
| Q26786428 | The role of renin-angiotensin aldosterone system related micro-ribonucleic acids in hypertension |
Search more.